189 related articles for article (PubMed ID: 35445903)
1. YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis.
Yang T; Hu Y; Chen S; Li L; Cao X; Yuan J; Shu F; Jiang Z; Qian S; Zhu X; Wei C; Wei R; Yan M; Li C; Yin X; Lu Q
Cell Biol Toxicol; 2023 Apr; 39(2):391-413. PubMed ID: 35445903
[TBL] [Abstract][Full Text] [Related]
2. Correction to: YY1 inactivated transcription co-regulator PGC-1α to promote mitochondrial dysfunction of early diabetic nephropathy-associated tubulointerstitial fibrosis.
Yang T; Hu Y; Chen S; Li L; Cao X; Yuan J; Shu F; Jiang Z; Qian S; Zhu X; Wei C; Wei R; Yan M; Li C; Yin X; Lu Q
Cell Biol Toxicol; 2023 Dec; 39(6):2787-2792. PubMed ID: 37115478
[TBL] [Abstract][Full Text] [Related]
3. YY1 was indispensable for the alleviation of quercetin on diabetic nephropathy-associated tubulointerstitial inflammation.
Yang T; Hu Y; Jiang W; Pang J; Zhou Y; Zhang H; Yin Z; Jiang Z; Qian S; Wei C; Yan M; Zhu X; Wang T; Lu Q
Phytomedicine; 2023 Mar; 111():154659. PubMed ID: 36641979
[TBL] [Abstract][Full Text] [Related]
4. Sirt1 inhibits renal tubular cell epithelial-mesenchymal transition through YY1 deacetylation in diabetic nephropathy.
Du L; Qian X; Li Y; Li XZ; He LL; Xu L; Liu YQ; Li CC; Ma P; Shu FL; Lu Q; Yin XX
Acta Pharmacol Sin; 2021 Feb; 42(2):242-251. PubMed ID: 32555442
[TBL] [Abstract][Full Text] [Related]
5. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
[TBL] [Abstract][Full Text] [Related]
6. Jujuboside A ameliorates tubulointerstitial fibrosis in diabetic mice through down-regulating the YY1/TGF-β1 signaling pathway.
Liu YY; Li L; Ji B; Hao SL; Kuang XF; Cao XY; Yuan JY; Jiang ZZ; Qian ST; Wei CJ; Xu J; Yin XX; Lu Q; Yang TT
Chin J Nat Med; 2022 Sep; 20(9):656-668. PubMed ID: 36162951
[TBL] [Abstract][Full Text] [Related]
7. Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.
Yang T; Heng C; Zhou Y; Hu Y; Chen S; Wang H; Yang H; Jiang Z; Qian S; Wang Y; Wang J; Zhu X; Du L; Yin X; Lu Q
Metabolism; 2020 Jul; 108():154258. PubMed ID: 32376130
[TBL] [Abstract][Full Text] [Related]
8. Tubular TMEM16A promotes tubulointerstitial fibrosis by suppressing PGC-1α-mediated mitochondrial homeostasis in diabetic kidney disease.
Ji JL; Li JY; Liang JX; Zhou Y; Liu CC; Zhang Y; Zhang AQ; Liu H; Ma RX; Li ZL
Cell Mol Life Sci; 2023 Nov; 80(12):347. PubMed ID: 37943391
[TBL] [Abstract][Full Text] [Related]
9. Sodium butyrate ameliorated diabetic nephropathy-associated tubulointerstitial inflammation by modulating the tight junctions of renal tubular epithelial cells.
Yang T; Li L; Heng C; Sha P; Wang Y; Shen J; Jiang Z; Qian S; Wei C; Yang H; Zhu X; Wang T; Wu M; Wang J; Lu Q; Yin X
Food Funct; 2024 Mar; 15(5):2628-2644. PubMed ID: 38358014
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy.
Liu L; Bai F; Song H; Xiao R; Wang Y; Yang H; Ren X; Li S; Gao L; Ma C; Yang X; Liang X
Redox Biol; 2022 Apr; 50():102260. PubMed ID: 35152003
[TBL] [Abstract][Full Text] [Related]
11. Alpha lipoamide inhibits diabetic kidney fibrosis via improving mitochondrial function and regulating RXRα expression and activation.
Zhang HF; Liu HM; Xiang JY; Zhou XC; Wang D; Chen RY; Tan WL; Liang LQ; Liu LL; Shi MJ; Zhang F; Xiao Y; Zhou YX; Zhang T; Tang L; Guo B; Wang YY
Acta Pharmacol Sin; 2023 May; 44(5):1051-1065. PubMed ID: 36347997
[TBL] [Abstract][Full Text] [Related]
12. Zinc Attenuates Tubulointerstitial Fibrosis in Diabetic Nephropathy Via Inhibition of HIF Through PI-3K Signaling.
Zhang X; Liang D; Fan J; Lian X; Zhao Y; Wang X; Chi ZH; Zhang P
Biol Trace Elem Res; 2016 Oct; 173(2):372-83. PubMed ID: 26956696
[TBL] [Abstract][Full Text] [Related]
13. Optineurin inhibits NLRP3 inflammasome activation by enhancing mitophagy of renal tubular cells in diabetic nephropathy.
Chen K; Feng L; Hu W; Chen J; Wang X; Wang L; He Y
FASEB J; 2019 Mar; 33(3):4571-4585. PubMed ID: 30571313
[TBL] [Abstract][Full Text] [Related]
14. Linc279227 contributes to mitochondrial dysfunction in high glucose-treated mouse renal tubular epithelial cells.
Qi C; Liang T; Lin J; Xie J; Cao D; Wang H; Li Q; Li S; Li J; Zhang Y; Wang Y; Li S; Chen Z; Yau H; Lin S; Zhang S; Liu S; Liang X; Zhang L; Wang W
Biochem Biophys Res Commun; 2023 Feb; 644():95-104. PubMed ID: 36640668
[TBL] [Abstract][Full Text] [Related]
15. Metformin attenuates renal tubulointerstitial fibrosis via upgrading autophagy in the early stage of diabetic nephropathy.
Wang F; Sun H; Zuo B; Shi K; Zhang X; Zhang C; Sun D
Sci Rep; 2021 Aug; 11(1):16362. PubMed ID: 34381133
[TBL] [Abstract][Full Text] [Related]
16. Advanced Oxidation Protein Products Aggravate Tubulointerstitial Fibrosis Through Protein Kinase C-Dependent Mitochondrial Injury in Early Diabetic Nephropathy.
Li X; Xu L; Hou X; Geng J; Tian J; Liu X; Bai X
Antioxid Redox Signal; 2019 Mar; 30(9):1162-1185. PubMed ID: 29482336
[TBL] [Abstract][Full Text] [Related]
17. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy.
Lu Q; Chen YB; Yang H; Wang WW; Li CC; Wang L; Wang J; Du L; Yin XX
Acta Pharmacol Sin; 2019 Dec; 40(12):1555-1567. PubMed ID: 31235817
[TBL] [Abstract][Full Text] [Related]
19. LncRNA KIFAP3-5:1 inhibits epithelial-mesenchymal transition of renal tubular cell through PRRX1 in diabetic nephropathy.
Du L; Lu Y; Wang J; Zheng Y; Li H; Liu Y; Wu X; Zhou J; Wang L; He L; Shi J; Xu L; Li X; Lu Q; Yin X
Cell Biol Toxicol; 2024 Jun; 40(1):47. PubMed ID: 38869718
[TBL] [Abstract][Full Text] [Related]
20. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
Zhao D; Jia J; Shao H
J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
